Navigation Links
Diabetes Injection Pens Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024
Date:1/3/2017

NEW YORK, Jan. 3, 2017 /PRNewswire/ -- Global Diabetes Injection Pens Market: Overview

This report on diabetes injection pens market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of diabetes injection pens products such as insulin pen and pen needles as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global diabetes injection pens market with respect to the leading market segments based on major products segment, end users, and geographies.

Global Diabetes Injection Pens Market: Segmentation

Based on the product type, the diabetes injection pens market has been segmented into: insulin pen and pen needles. In term of diabetes injection pen usage products divided into reusable pens and disposable pens. Each of the market segments have been extensively analyzed based on the market related factors such as increasing rate of diabetes incidences worldwide, technological advancement, and growing number of use of reusable pens in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Global Diabetes Injection Pens Market: Drivers and Trends

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the diabetes injection pens market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global diabetes injection pens market.

Global Diabetes Injection Pens Market: Geographical Outlook

Geographically, diabetes injection pens market has been segmented into five major regions: North America, Europe, Asia, Latin America, and Rest of World. The market size and forecast for each of these regions has been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter's five forces analysis, value chain analysis, pricing analysis and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global diabetes injection pens market.

Key Players Mentioned in this Report are:

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global diabetes injection pens market. The report also profiles key players operating in the diabetes injection pens market which are Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca plc, Biocon Ltd., Sanofi S.A., Becton, Dickinson and Company, Owen Mumford Ltd., Jiangsu Delfu Co. and Wockhardt Ltd. The global diabetes injection pens market is dominated by three global vendors that accounts for more than 74% share of the global market.

The global diabetes injection pens market is segmented as follows:

Global Diabetes Injection Pens Market, by Product Type

Insulin Pens
Pen Needles

Global Diabetes Injection Pens Market, by Usage

Reusable Pens
Disposable Pens

Global Diabetes Injection Pens Market, by Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Sales
Diabetes Clinics/ Centers

Global Diabetes Injection Pens Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of the Europe
Asia
China
Japan
India
Indonesia
Malaysia
Rest of Asia
Latin America (LATAM)
Brazil
Mexico
Rest of LATAM
Rest of World
Australia & New Zealand
South Africa
RoW
Read the full report: http://www.reportlinker.com/p04589993-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/diabetes-injection-pens-market---global-industry-analysis-size-share-growth-trends--forecast-2016---2024-300384932.html


'/>"/>
SOURCE Reportlinker
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Diabetes Injection Pens Market is Expected to be Worth US$9.7 Billion by 2024 - Leading Players Operating are Novo Nordisk A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and Sanofi S.A
2. Diabetes drug slows experimental Parkinsons disease progression, human trials to begin next year
3. Diabetes & Obesity Drug Development Pipeline Review, 2016
4. Physicians Move Beyond Traditional Tests to Better Manage Diabetes
5. FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes
6. United States Lancet and Lancing Devices Market Report 2016-2017 with Diabetes Monitoring, Treatment And Drug Delivery Market Overview - Research and Markets
7. Unmet Needs in Type 2 Diabetes Mellitus Market Leave Ample Opportunity for Investment, Says GBI Research
8. Emperra Wins Prestigious Award With Innovative Diabetes Device
9. Intarcia Submits New Drug Application (NDA) to FDA for U.S. Marketing Approval of ITCA 650 in Type 2 Diabetes
10. Diabetes Scholars Foundation Announces 2016 Scholarship Recipients
11. Medical Imaging Leaders Tap IBM and Watson to Tackle Cancer, Diabetes, Eye Health, Brain Disease and Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2020)... ... 02, 2020 , ... Adoptive cell therapies have ushered in ... of two Chimeric Antigen Receptor T-Cell (CAR-T) therapies in 2017. In addition to ... (TCR-Ts), Natural Killer (NKs) cells and Dendritic Cells (DCs). , In this webinar, ...
(Date:6/2/2020)... ... June 02, 2020 , ... ... medical professionals, but confidence in those sources varies widely. A recent national survey ... Sciences finds that Americans are more likely to trust information that comes from ...
(Date:5/30/2020)... ... May 29, 2020 , ... ... return-to-work mobile and web based solution People1 Care to help organizations ... companies transition into the 'new normal’ through daily wellness screenings, social distancing support, ...
Breaking Medicine Technology:
(Date:5/27/2020)... ... May 27, 2020 , ... Radiology ... in the United States, has aligned with the Strategic Radiology (SR) coalition of ... Virginia to join the SR coalition, which has 28 member practices in 20 ...
(Date:5/26/2020)... ... May 26, 2020 , ... Today TRC Companies (“ TRC ... online tool that will help business owners and leaders assess whether their organizations are ... This latest offering from TRC is intended to assist business leaders evaluate their readiness ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... to the CRC’s Guide to Coordinating Clinical Research, CenterWatch eLearning , ... management, The CRC Trainer: An Interactive Companion to the CRC’s Guide to ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... experience of GSCG, VITA NOVAS has already gained ground with the inherited reputation ... and stimulating biological products intravenously, guaranteeing an effective way for the ingredients to ...
(Date:5/21/2020)... AUSTIN, Texas (PRWEB) , ... May 21, 2020 , ... ... fire departments and hospitals, today announced the findings of its 2020 ESO Fire ... the number of EMS calls versus fire-related calls, first apparatus turnout time and travel ...
Breaking Medicine News(10 mins):